I. Rosselló

发表

Cost analysis of disease including treatment with dalbavancin in a Spanish hospital: ECODAL ANALYSIS.

M. Valerio, C. Crespo, M. Sánchez-Somolinos, 2023, Journal of medical economics.

Dalbavancin in clinical practice in Spain: a 2 year retrospective study

M. Salavert, J. Aguado, B. Almirante, 2022, JAC-antimicrobial resistance.

The treatment of scaphoid non-unions with partial and total scaphoid in titanium custom-made 3D-printed prostheses and reconstruction of scapholunate interosseous ligament: a preliminary study

A. Cioffi, I. Rosselló, 2021, medRxiv.

Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus.

L. Soldevila, O. Murillo, J. Gómez-Junyent, 2022, International journal of antimicrobial agents.